Paperpal Prime Logo

Toxicology and Applied Pharmacology : Impact Factor & More

eISSN: 1096-0333pISSN: 0041-008X

Aims and Scope of Toxicology and Applied Pharmacology

Toxicology and Applied Pharmacology is a scientific journal for original research pertaining to action of chemicals, drugs, or natural products to animals or humans. The journal covers mechanistic approaches to physiological, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Less

Key Metrics

CiteScore
7.1
Impact Factor
< 5
SJR
Q1Toxicology
SNIP
0.97
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Toxicology and Applied Pharmacology

Toxicology and Applied Pharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ACADEMIC PRESS INC ELSEVIER SCIENCE
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year1959
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Toxicology and Applied Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Toxicology and Applied Pharmacology

A fully human antibody A140 neutralizes abrin toxin via lysosomal intracellular mechanisms, confers potent protection in vitro and in vivo, and reverses transcriptomic dysregulation with a Favorable safety profile.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
Brefeldin A induces apoptosis in cisplatin-resistant ovarian cancer cells independent of ABCC2-mediated drug efflux.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
In vitro assessment of the osteotoxic potential of diuron in human BMSCs.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
Asiaticoside alleviates metabolic associated fatty liver disease via PI3K/AKT/mTOR signaling pathway.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
Corynoxine suppresses hepatocellular carcinoma progression by forming the ROS-STAT3 cycle.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
Etanercept suppresses rheumatoid arthritis development via modulating miR-125a-3p.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
A fully human antibody A140 neutralizes abrin toxin via lysosomal intracellular mechanisms, confers potent protection in vitro and in vivo, and reverses transcriptomic dysregulation with a Favorable safety profile.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
Brefeldin A induces apoptosis in cisplatin-resistant ovarian cancer cells independent of ABCC2-mediated drug efflux.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
In vitro assessment of the osteotoxic potential of diuron in human BMSCs.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
Asiaticoside alleviates metabolic associated fatty liver disease via PI3K/AKT/mTOR signaling pathway.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
Corynoxine suppresses hepatocellular carcinoma progression by forming the ROS-STAT3 cycle.
  • 1 Sep 2026
  • Toxicology and applied pharmacology
Etanercept suppresses rheumatoid arthritis development via modulating miR-125a-3p.
  • 1 Sep 2026
  • Toxicology and applied pharmacology

FAQs on Toxicology and Applied Pharmacology